A group of House Democrats chanted in support of Speaker Nancy PelosiNancy PelosiRepublicans caught in California's recall trap Raise the debt limit while starting to fix the budget 'Justice for J6' organizer calls on demonstrators to respect law enforcement MORE's (D-Calif.) signature drug pricing bill during President TrumpDonald TrumpKinzinger says Trump 'winning' because so many Republicans 'have remained silent' Our remote warfare counterterrorism strategy is more risk than reward Far-right rally draws small crowd, large police presence at Capitol MORE's State of the Union address Tuesday.
As Trump delivers his speech Tuesday night, the Democrats chanted "H.R. 3," a reference to Pelosi's bill that passed the House late last year. Every House Democrat voted for the measure.
WATCH: Democrats chant "HR 3," referencing bill on drug prices, in response to President Trump's call for legislation to lower prescription drug prices. pic.twitter.com/zqbUvoldWB— NBC News (@NBCNews) February 5, 2020
Among other provisions, the legislation calls for Medicare to negotiate drug prices.
But Senate Majority Leader Mitch McConnellAddison (Mitch) Mitchell McConnell'Justice for J6' rally puts GOP in awkward spot Republicans keep distance from 'Justice for J6' rally House to act on debt ceiling next week MORE (R-Ky.) has called the bill socialism and said it will not pass the Republican-controlled upper chamber.
The chanting erupted after Trump urged lawmakers to pass bipartisan drug pricing legislation. Trump said he would sign legislation if it got to his desk.
Pelosi spent months in talks with Trump to try to get him to support the bill. During the 2016 campaign, Trump famously broke with his party and said he supported letting the government negotiate drug prices.
But the White House distanced itself from Pelosi’s bill and eventually came out against the legislation. Trump said Pelosi's bill would impose “price controls” and indicated he would veto it.
Lowering drug prices is seen as a rare area of possible bipartisan action, and it polls consistently as one of the top issues for voters. Democrats and progressive groups plan to spotlight the bill as the central piece to their health messaging in 2020.